Cognex Corporation $CGNX Shares Sold by US Bancorp DE

US Bancorp DE lowered its position in shares of Cognex Corporation (NASDAQ:CGNX) by 6.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,245 shares of the scientific and technical instruments company’s stock after selling 2,448 shares during the period. US Bancorp DE’s holdings in Cognex were worth $1,150,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of CGNX. Geneos Wealth Management Inc. grew its stake in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares in the last quarter. Farther Finance Advisors LLC grew its stake in shares of Cognex by 439.4% during the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company’s stock worth $29,000 after purchasing an additional 791 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Cognex by 155.3% during the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company’s stock worth $32,000 after purchasing an additional 646 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its stake in shares of Cognex by 231.9% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock worth $34,000 after purchasing an additional 756 shares in the last quarter. Finally, Global X Japan Co. Ltd. acquired a new position in shares of Cognex during the first quarter worth $38,000. Institutional investors and hedge funds own 88.12% of the company’s stock.

Insider Activity

In other news, EVP Sheila Marie Dipalma sold 2,002 shares of the stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $45.00, for a total value of $90,090.00. Following the completion of the transaction, the executive vice president owned 8,582 shares in the company, valued at $386,190. This trade represents a 18.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Cognex Stock Down 0.6%

NASDAQ CGNX opened at $46.04 on Friday. The stock has a market capitalization of $7.73 billion, a P/E ratio of 64.85 and a beta of 1.50. Cognex Corporation has a 52-week low of $22.67 and a 52-week high of $47.52. The firm has a 50-day moving average price of $44.62 and a 200 day moving average price of $35.42.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.02. The firm had revenue of $249.09 million during the quarter, compared to analysts’ expectations of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The firm’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities research analysts expect that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were issued a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex’s dividend payout ratio (DPR) is currently 45.07%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Needham & Company LLC boosted their target price on shares of Cognex from $36.00 to $45.00 and gave the stock a “buy” rating in a research note on Thursday, July 31st. JPMorgan Chase & Co. began coverage on shares of Cognex in a research note on Monday, September 15th. They issued a “neutral” rating and a $45.00 price objective for the company. Weiss Ratings restated a “hold (c)” rating on shares of Cognex in a research note on Wednesday, October 8th. Citigroup restated a “neutral” rating and issued a $37.00 price objective (up previously from $30.00) on shares of Cognex in a research note on Monday, July 14th. Finally, UBS Group upped their price objective on shares of Cognex from $53.00 to $58.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Cognex presently has an average rating of “Moderate Buy” and an average target price of $44.93.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.